$UAMY
UNITED STATES ANTIMONY CORP Stock $uamy

$uamy Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000165495423013006 Filed on October 17, 2023

Income Statement

Concept	2023 Q4	2023 Q2	2023 Q1
Revenue	$1.665M	$2.504M	$2.211M
YoY Change	17.26%	-30.22%	-38.25%
Cost Of Revenue	$3.709M	$2.208M	$2.746M
YoY Change	117.05%	-22.96%	12.51%
Gross Profit	-$2.044M	$295.9K	-$535.4K
YoY Change	607.53%	-59.04%	-146.99%
Gross Profit Margin	-122.76%	11.82%	-24.22%
Selling, General & Admin	$1.097M	$763.0K	$368.1K
YoY Change	135.4%	123.47%	3.43%
% of Gross Profit		257.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$245.1K	$241.1K	$224.2K
YoY Change	13.9%	4.35%	1.86%
% of Gross Profit		81.48%
Operating Expenses	$1.460M	$806.0K	$476.4K
YoY Change	159.73%	126.73%	32.41%
Operating Profit	-$3.505M	-$510.1K	-$1.012M
YoY Change	311.73%	-239.01%	-229.8%
Interest Expense	$155.2K	$162.2K	$197.4K
YoY Change	344.57%	5165.82%	6518.04%
% of Operating Profit
Other Income/Expense, Net	$6.980K	$173.6K	$204.9K
YoY Change	-90.13%	-3139.64%	2970.62%
Pretax Income	-$3.560M	-$336.5K	-$807.0K
YoY Change	377.55%	-191.7%	-203.51%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.562M	-$336.5K	-$807.0K
YoY Change	360.57%	-193.15%	-202.64%
Net Earnings / Revenue	-213.91%	-13.44%	-36.5%
Basic Earnings Per Share		$107.6M	$107.3M
Diluted Earnings Per Share	-$0.03	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	107.6M shares	107.6M shares	107.3M shares
Diluted Shares Outstanding		107.6M shares	107.3M shares

Balance Sheet

Concept	2023 Q4	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.97M	$13.95M	$15.62M
YoY Change	-38.03%	-36.23%	-27.66%
Cash & Equivalents	$11.90M	$13.69M	$15.36M
Short-Term Investments	$72.90K	$259.9K	$259.9K
Other Short-Term Assets	$92.37K	$377.8K	$279.5K
YoY Change	-32.87%	520.19%
Inventory	$1.386M	$2.350M	$1.610M
Prepaid Expenses
Receivables	$625.3K	$1.308M	$1.704M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$14.08M	$17.98M	$19.21M
YoY Change	-34.88%	-25.47%	-20.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.45M	$13.01M	$12.52M
YoY Change	10.94%	15.73%	12.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$509.2K	$1.219M	$1.071M
YoY Change	-46.68%	270.18%	277.44%
Total Long-Term Assets	$14.02M	$14.29M	$13.65M
YoY Change	7.15%	22.85%	19.26%
TOTAL ASSETS
Total Short-Term Assets	$14.08M	$17.98M	$19.21M
Total Long-Term Assets	$14.02M	$14.29M	$13.65M
Total Assets	$28.09M	$32.27M	$32.86M
YoY Change	-19.04%	-9.75%	-7.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$456.9K	$407.1K	$835.7K
YoY Change	-27.33%	-40.09%	-24.55%
Accrued Expenses	$133.8K	$224.5K	$169.4K
YoY Change	-51.17%	-67.27%	-72.88%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$28.44K	$82.57K	$95.57K
YoY Change	-69.79%	-9.61%	677.84%
Total Short-Term Liabilities	$897.5K	$977.9K	$1.209M
YoY Change	-59.57%	-33.06%	-30.69%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$183.1K	$193.4K
YoY Change	-100.0%	-48.72%	-2.71%
Other Long-Term Liabilities	$1.677M	$382.5K	$396.8K
YoY Change	326.1%	-25.46%	-10.02%
Total Long-Term Liabilities	$0.00	$183.1K	$193.4K
YoY Change	-100.0%	-48.72%	-2.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$897.5K	$977.9K	$1.209M
Total Long-Term Liabilities	$0.00	$183.1K	$193.4K
Total Liabilities	$2.574M	$1.544M	$1.799M
YoY Change	-9.08%	-31.09%	-24.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.42M	-$34.21M	-$33.88M
YoY Change	19.2%	8.4%	6.12%
Common Stock	$1.076M	$1.076M	$1.076M
YoY Change	1.2%	1.32%	1.32%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$0.00	$0.00
YoY Change	-100.0%
Treasury Stock Shares
Shareholders Equity	$25.52M	$30.73M	$31.06M
YoY Change
Total Liabilities & Shareholders Equity	$28.09M	$32.27M	$32.86M
YoY Change	-19.04%	-9.75%	-7.53%

Cashflow Statement

Concept	2023 Q4	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.562M	-$336.5K	-$807.0K
YoY Change	360.57%	-193.15%	-202.64%
Depreciation, Depletion And Amortization	$245.1K	$241.1K	$224.2K
YoY Change	13.9%	4.35%	1.86%
Cash From Operating Activities	-$932.1K	-$917.7K	-$2.274M
YoY Change	242.45%	-257.92%	-1487.28%
INVESTING ACTIVITIES
Capital Expenditures	$8.950K	$733.1K	$614.8K
YoY Change	-99.21%	-476.99%	226.07%
Acquisitions
YoY Change
Other Investing Activities	$187.0K	$0.00
YoY Change	-98.57%	-100.0%
Cash From Investing Activities	$178.0K	-$733.1K	-$614.8K
YoY Change	-98.5%	-94.6%	226.07%
FINANCING ACTIVITIES
Cash Dividend Paid			$787.7K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$23.02K
YoY Change			467.46%
Cash From Financing Activities	-213.5K	-23.35K	-$810.8K
YoY Change	-5.38%	48.63%	19884.03%
NET CHANGE
Cash From Operating Activities	-932.1K	-917.7K	-$2.274M
Cash From Investing Activities	178.0K	-733.1K	-$614.8K
Cash From Financing Activities	-213.5K	-23.35K	-$810.8K
Net Change In Cash	-967.6K	-1.674M	-$3.699M
YoY Change	-108.49%	-87.14%	12791.84%
FREE CASH FLOW
Cash From Operating Activities	-$932.1K	-$917.7K	-$2.274M
Capital Expenditures	$8.950K	$733.1K	$614.8K
Free Cash Flow	-$941.1K	-$1.651M	-$2.889M
YoY Change	-33.09%	-312.84%	11624.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Inventory Net InventoryNet	1375068	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	21617359	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12128124	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	57288	usd
CY2023Q2	us-gaap	Revenues Revenues	2503573	usd
CY2022Q2	us-gaap	Revenues Revenues	3587925	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	295896	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	722410	usd
CY2023Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	43003	usd
CY2022Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	14045	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	253205	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	47927	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	805985	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	355475	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	290153	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	39706	usd
	us-gaap	Net Income Loss NetIncomeLoss	1147475	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1147199	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1123836	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	897679	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000101538
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	107647317	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	106373341	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-08675
	dei	Entity Registrant Name EntityRegistrantName	UNITED STATES ANTIMONY CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MT
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	81-0305822
	dei	Entity Address Address Line1 EntityAddressAddressLine1	P.O. Box 643
	dei	Entity Address City Or Town EntityAddressCityOrTown	Thompson Falls
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	59873
	dei	City Area Code CityAreaCode	406
	dei	Local Phone Number LocalPhoneNumber	827-3523
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	UAMY
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107647317	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19060378	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	259857	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	784457	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	137599	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	628803	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	212654	usd
CY2022Q4	uamy	Due To Related Party Current DueToRelatedPartyCurrent	61458	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	435075	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	787730	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	94150	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2219870	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	107647317	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	106373341	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1076472	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1063732	usd
	us-gaap	Revenues Revenues	4714417	usd
	us-gaap	Revenues Revenues	7168231	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	2207677	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	2865515	usd
	us-gaap	Cost Of Revenue CostOfRevenue	4953940	usd
	us-gaap	Cost Of Revenue CostOfRevenue	5306433	usd
	us-gaap	Gross Profit GrossProfit	-239523	usd
	us-gaap	Gross Profit GrossProfit	1861798	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	364365	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	220591	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	519959	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	381272	usd
CY2023Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	145412	usd
CY2022Q2	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	72912	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	273104	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	146047	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	151348	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	17960	usd
	us-gaap	Professional Fees ProfessionalFees	338011	usd
	us-gaap	Professional Fees ProfessionalFees	170004	usd
	us-gaap	Operating Expenses OperatingExpenses	1282422	usd
	us-gaap	Operating Expenses OperatingExpenses	715283	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-510089	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	366935	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1521945	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1146515	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	167781	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	30052	usd
CY2023Q2	uamy	Change In Fair Value Of Investments Net ChangeInFairValueOfInvestmentsNet	0	usd
CY2022Q2	uamy	Change In Fair Value Of Investments Net ChangeInFairValueOfInvestmentsNet	-93458	usd
	uamy	Change In Fair Value Of Investments Net ChangeInFairValueOfInvestmentsNet	0	usd
	uamy	Change In Fair Value Of Investments Net ChangeInFairValueOfInvestmentsNet	-93458	usd
CY2023Q2	uamy	Income From Trademark And Licensing IncomeFromTrademarkAndLicensing	11381	usd
CY2022Q2	uamy	Income From Trademark And Licensing IncomeFromTrademarkAndLicensing	60775	usd
	uamy	Income From Trademark And Licensing IncomeFromTrademarkAndLicensing	18906	usd
	uamy	Income From Trademark And Licensing IncomeFromTrademarkAndLicensing	60775	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5538	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3081	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69437	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6063	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	173624	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5712	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	378496	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	960	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-336465	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	361223	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1143449	usd
CY2023Q2	uamy	Preferred Dividends PreferredDividends	-1875	usd
CY2022Q2	uamy	Preferred Dividends PreferredDividends	-11819	usd
	uamy	Preferred Dividends PreferredDividends	-3750	usd
	uamy	Preferred Dividends PreferredDividends	-23639	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-338340	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	349404	usd
CY2023Q2	uamy	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	-0.01
CY2022Q2	uamy	Earning Per Share Basic And Diluted EarningPerShareBasicAndDiluted	0.01
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106240361	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107504628	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106240361	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106240361	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	107504628	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106240361	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	32368803	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	786252	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	33155055	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	361223	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	33516278	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31869255	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	0	usd
CY2023Q1	uamy	Conversion Of Preferred Series D To Common Stock Amount ConversionOfPreferredSeriesDToCommonStockAmount	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-806984	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	31062271	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-336465	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	30725806	usd
	us-gaap	Profit Loss ProfitLoss	-1143449	usd
	us-gaap	Profit Loss ProfitLoss	1147475	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	465341	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	451207	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	6736	usd
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	11412	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	75000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	456238	usd
	us-gaap	Inventory Write Down InventoryWriteDown	136836	usd
	uamy	Changes In Fair Value Of Investments Net ChangesInFairValueOfInvestmentsNet	0	usd
	uamy	Changes In Fair Value Of Investments Net ChangesInFairValueOfInvestmentsNet	93458	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-523517	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-713346	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1431475	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	328380	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-240225	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-60916	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-320820	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-86442	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-221673	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-706155	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	11856	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	64045	usd
	uamy	Increase Decrease In Due To Related Party IncreaseDecreaseInDueToRelatedParty	139208	usd
	uamy	Increase Decrease In Due To Related Party IncreaseDecreaseInDueToRelatedParty	4084	usd
	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-389716	usd
	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3191496	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	745038	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	13789772	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	0	usd
	us-gaap	Proceeds From Sale Of Longterm Investments ProceedsFromSaleOfLongtermInvestments	396921	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1347856	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	382999	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1347856	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13775850	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	46369	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	19767	usd
	uamy	Dividends Paid DividendsPaid	787730	usd
	uamy	Dividends Paid DividendsPaid	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-834099	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19767	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5373451	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13050579	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19117666	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21420329	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13744215	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8369750	usd
	uamy	Retirement Of Common Stock RetirementOfCommonStock	202980	shares
	uamy	Conversion Of Preferred Series D To Common Stock ConversionOfPreferredSeriesDToCommonStock	16927	usd
	uamy	Conversion Of Preferred Series D To Common Stock ConversionOfPreferredSeriesDToCommonStock	0	usd
	uamy	Equipment Purchased With Note Payable EquipmentPurchasedWithNotePayable	0	usd
	uamy	Equipment Purchased With Note Payable EquipmentPurchasedWithNotePayable	161600	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12923713	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12128124	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 - NATURE OF OPERATIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC”, the “Company”, or “Our”) sell processed antimony, zeolite, and precious metals products in the U.S. and abroad. The Company processes antimony ore in the U.S. and Mexico primarily into antimony oxide and antimony metal at its facilities in Montana and Mexico. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications.</p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain reclassifications have been made to conform prior period amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported. </p>
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	12346215	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	14182594	usd
CY2023Q2	us-gaap	Revenues Revenues	2503573	usd
CY2022Q2	us-gaap	Revenues Revenues	3587925	usd
	us-gaap	Revenues Revenues	4714417	usd
	us-gaap	Revenues Revenues	7168231	usd
CY2023Q2	us-gaap	Contract With Customer Receivable Allowance For Credit Loss ContractWithCustomerReceivableAllowanceForCreditLoss	1307974	usd
CY2022Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss ContractWithCustomerReceivableAllowanceForCreditLoss	784457	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	75000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	31440	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	2350305	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1375068	usd
	us-gaap	Inventory Write Down InventoryWriteDown	456238	usd
	us-gaap	Inventory Write Down InventoryWriteDown	136836	usd
CY2023Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18065882	usd
CY2023Q2	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3029634	usd
CY2023Q2	us-gaap	Land Land	5304177	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26399693	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13389054	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13010639	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17195914	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2160805	usd
CY2022Q4	us-gaap	Land Land	5244177	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	450941	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25051837	usd
CY2023Q2	uamy	Assets Not Yet Placed In Service AssetsNotYetPlacedInService	280406	usd
CY2022Q4	uamy	Assets Not Yet Placed In Service AssetsNotYetPlacedInService	1117041	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	265636	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	312005	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	82573	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	94150	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	183063	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	217855	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	82573	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	12924	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	13219	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	156920	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	265636	usd
CY2023Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	45359	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	435075	usd
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1692672	shares
CY2023Q1	uamy	Cash Paid To Shareholders CashPaidToShareholders	787730	usd
CY2023Q1	uamy	Description Of Returned Of Shares DescriptionOfReturnedOfShares	the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	12346215	shares
CY2023Q2	uamy	Warrants Exercised Exercise Price WarrantsExercisedExercisePrice	0.75
CY2023Q2	us-gaap	Assets Assets	32269313	usd
CY2022Q4	us-gaap	Assets Assets	34700450	usd
CY2023Q2	uamy	Capital Expenditure CapitalExpenditure	733086	usd
CY2022Q2	uamy	Capital Expenditure CapitalExpenditure	371654	usd
	uamy	Capital Expenditure CapitalExpenditure	1347856	usd
	uamy	Capital Expenditure CapitalExpenditure	544599	usd
CY2023Q2	us-gaap	Revenues Revenues	2503573	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	241100	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-510089	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	173624	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-336465	usd
CY2022Q2	us-gaap	Revenues Revenues	3587925	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	231057	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	366935	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5712	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	361223	usd
	us-gaap	Revenues Revenues	4714417	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	465341	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	378496	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1143449	usd
	us-gaap	Revenues Revenues	7168231	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	451207	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1146515	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	960	usd
	us-gaap	Net Income Loss NetIncomeLoss	1147475	usd

Files In Submission

Name	View Source	Status
0001654954-23-013006-index-headers.html	Edgar Link	pending
0001654954-23-013006-index.html	Edgar Link	pending
0001654954-23-013006.txt	Edgar Link	pending
0001654954-23-013006-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uamy-20230630.xsd	Edgar Link	pending
uamy_10q.htm	Edgar Link	pending
uamy_ex311.htm	Edgar Link	pending
uamy_ex312.htm	Edgar Link	pending
uamy_ex321.htm	Edgar Link	pending
uamy_ex322.htm	Edgar Link	pending
uamy-20230630_pre.xml	Edgar Link	unprocessable
uamy-20230630_cal.xml	Edgar Link	unprocessable
uamy-20230630_def.xml	Edgar Link	unprocessable
uamy-20230630_lab.xml	Edgar Link	unprocessable
uamy_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UAMY
UNITED STATES ANTIMONY CORP Stock $uamy

2023 Q4 Form 10-Q Financial Statement

#000165495423013006 Filed on October 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAMY UNITED STATES ANTIMONY CORP Stock $uamy

2023 Q4 Form 10-Q Financial Statement

#000165495423013006 Filed on October 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UAMY
UNITED STATES ANTIMONY CORP Stock $uamy